Personal information

Other IDs

Loop profile: 1511896

Activities

Collapse all

Employment (1)

Affiliated Hospital of Nantong University: Nantong, CN

Employment
Source: Self-asserted source
fei song

Education and qualifications (1)

Nantong University: Nantong, CN

2020-09-01 to 2024-06-01 | Doctor
Education
Source: Self-asserted source
fei song

Works (6)

Enhancement of gemcitabine sensitivity in intrahepatic cholangiocarcinoma through Saikosaponin-a mediated modulation of the p-AKT/BCL-6/ABCA1 axis.

Phytomedicine : international journal of phytotherapy and phytopharmacology
2024-08-08 | Journal article
DOI: 10.1016/j.phymed.2024.155944
PMID: 39146879
Contributors: Song F; Wang CG; Wang TL; Tao YC; Mao JZ; Hu CW; Zhang Y; Tang PJ; Lu CL; Qing HL et al.
Source: Self-asserted source
fei song

Anlotinib potentiates anti-PD1 immunotherapy via transferrin receptor-dependent CD8<sup>+</sup> T-cell infiltration in hepatocellular carcinoma.

Clinical and translational medicine
2024-08-01 | Journal article
DOI: 10.1002/ctm2.1738
PMID: 39095323
PMC: PMC11296886
Contributors: Song F; Hu B; Liang XL; Cheng JW; Wang CG; Wang PX; Wang TL; Tang PJ; Sun HX; Guo W et al.
Source: Self-asserted source
fei song

PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma

Frontiers in Immunology
2023-06-15 | Journal article
DOI: 10.3389/fimmu.2023.1197152
Part of ISSN: 1664-3224
Contributors: Fei Song; Cheng-Gui Wang; Jia-Zhen Mao; Tian-Lun Wang; Xiao-Liang Liang; Chen-Wei Hu; Yu Zhang; Lu Han; Zhong Chen
Source: Self-asserted source
fei song

Uncovering the mechanism of Kang-ai injection for treating intrahepatic cholangiocarcinoma based on network pharmacology, molecular docking, and in vitro validation

Frontiers in Pharmacology
2023-03-02 | Journal article
DOI: 10.3389/fphar.2023.1129709
Part of ISSN: 1663-9812
Contributors: Fei Song; Chang-Liang Lu; Cheng-Gui Wang; Chen-Wei Hu; Yu Zhang; Tian-Lun Wang; Lu Han; Zhong Chen
Source: Self-asserted source
fei song

Mucin 1 promotes tumor progression through activating WNT/β-catenin signaling pathway in intrahepatic cholangiocarcinoma

Journal of Cancer
2021 | Journal article
DOI: 10.7150/jca.63235
Part of ISSN: 1837-9664
Source: Self-asserted source
fei song
grade
Preferred source (of 2)‎

Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma

Cell Death & Disease
2020-06 | Journal article
DOI: 10.1038/s41419-020-02749-7
Part of ISSN: 2041-4889
Source: Self-asserted source
fei song

Peer review (1 review for 1 publication/grant)

Review activity for Journal of experimental & clinical cancer research. (1)
How many people are using ORCID?